Credentials
Medical License: Expiration: 12/31/05 Alabama 2001 Diplomate - American Board of Internal Medicine 1999 Diplomate - American Board of Internal Medicine
Education: 1984 - 1988 B.A. - University of Tennessee , College of Scholars Program, Knoxville, Tennessee 1988 - 1995 M.D., PhD - Yale University School of Medicine, Medical Scientist Training Program, New Haven, Connecticut 1995 - 1997
Internship: Resident in Internal Medicine, Yale-New Haven Hospital, New Haven, Connecticut 1997 - 2001
Residency: Gastroenterology Fellow, Yale University School of Medicine, New Haven, Connecticut
Work Experience: 2003: Present Principle Investigator - Medical Affiliated Research Center, Inc. 303 Williams Avenue, Suite 512, Huntsville, Alabama 1999 Guest Lecturer - Danbury Hospital; Lecture topic "Screening Strategies for GI Malignancies"., Danbury, Connecticut
1999: Guest Lecturer- Yale New Haven Hospital; Guest Lecturer to Medical students and residents. Lecture topic "Hepatitis C","Acute Pancreatitis", "Wilson's Disease", "Mechanisms of Cyclosporin Actions" and "Why Beer and Wine but no Spirits
1997: Present GI Physiology/Pathology Lecturer- PA Physiology Class; Lectured in the PA Physiology Class; topics included "The Physiologic response to meal", "Acute Pancreatitis"
1996: Present Clinical Skills Instructor- Yale University School of Medicine 1993-1995: Teacher- PA Physiology Class; Prepared and delivered all of the lectures in the cardiovascular section of the PA Physiology class.
1992-1999: Medical Textbook Reviewer- W.B. Saunders Publishers, New York, New York
1990-1993: Microbiology Teacher- Hillhouse High School; Taught microbiology and molecular biology to advanced students in the 12th grade as part of Macy's Program for the Advancement of Science in high schools., New Haven, Connecticut
Research Activities: Endocrinology-Diabetes - Type Unspecified
1. Effects of Insulin and Dexamethasone on the Expression of c-myc protoncogene in Reuber H 35 Hepatoma cells. Gastroenterology-Diabetic Gastroparesis
2. A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Dose- Finding Study to Evaluate the Safety and Efficacy of XXXXX in Patients with Diabetic Gastroparesis Gastroenterology-Functional Dyspepsia
3. A Six-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study, to Assess the Efficacy and Safety of XXXXX, and Placebo, in Female Patients
4. A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Dose-Ranging Study of XXXXX in Subjects with Functional Dyspepsia Gastroenterology Gastroesophageal Reflux Disease
5. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of XXXXX Alone, and in Combination with Omeprazole, Given Orally in Patients Suffering from Symptomatic (non-erosive) Gastroesophageal Reflux Disease(sGERD)
6. Post-Doctoral Fellowship Section of Digestive Diseases at Yale University & West Haven-VA Medical Center
7. Multi-Center, Randomized, Double-Blind, Placebo-Controlled Efficacy Study, Comparing Four Weeks of Treatment with XXXXX and XXXXX in Patients with Heartburn, and Sleep Disturbances, Associated with Gastroesophageal Reflux Disease (GERD) Gastroenterology-Hepatitis C Virus
8. A Comparison of the Safety and Efficacy of Two Doses of Peg-Interferon alfa-2b (PEG-Intron: 1.5 ug/kg vs. 3.0 ug/kg) in Combination with Ribavarin (Rebetol) Treatment of Chronic Hepatitis C Patients: Gastroenterology-Irritable Bowel Syndrome
Medical License: Expiration: 12/31/05 Alabama 2001 Diplomate - American Board of Internal Medicine 1999 Diplomate - American Board of Internal Medicine
Education: 1984 - 1988 B.A. - University of Tennessee , College of Scholars Program, Knoxville, Tennessee 1988 - 1995 M.D., PhD - Yale University School of Medicine, Medical Scientist Training Program, New Haven, Connecticut 1995 - 1997
Internship: Resident in Internal Medicine, Yale-New Haven Hospital, New Haven, Connecticut 1997 - 2001
Residency: Gastroenterology Fellow, Yale University School of Medicine, New Haven, Connecticut
Work Experience: 2003: Present Principle Investigator - Medical Affiliated Research Center, Inc. 303 Williams Avenue, Suite 512, Huntsville, Alabama 1999 Guest Lecturer - Danbury Hospital; Lecture topic "Screening Strategies for GI Malignancies"., Danbury, Connecticut
1999: Guest Lecturer- Yale New Haven Hospital; Guest Lecturer to Medical students and residents. Lecture topic "Hepatitis C","Acute Pancreatitis", "Wilson's Disease", "Mechanisms of Cyclosporin Actions" and "Why Beer and Wine but no Spirits
1997: Present GI Physiology/Pathology Lecturer- PA Physiology Class; Lectured in the PA Physiology Class; topics included "The Physiologic response to meal", "Acute Pancreatitis"
1996: Present Clinical Skills Instructor- Yale University School of Medicine 1993-1995: Teacher- PA Physiology Class; Prepared and delivered all of the lectures in the cardiovascular section of the PA Physiology class.
1992-1999: Medical Textbook Reviewer- W.B. Saunders Publishers, New York, New York
1990-1993: Microbiology Teacher- Hillhouse High School; Taught microbiology and molecular biology to advanced students in the 12th grade as part of Macy's Program for the Advancement of Science in high schools., New Haven, Connecticut
Research Activities: Endocrinology-Diabetes - Type Unspecified
1. Effects of Insulin and Dexamethasone on the Expression of c-myc protoncogene in Reuber H 35 Hepatoma cells. Gastroenterology-Diabetic Gastroparesis
2. A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Dose- Finding Study to Evaluate the Safety and Efficacy of XXXXX in Patients with Diabetic Gastroparesis Gastroenterology-Functional Dyspepsia
3. A Six-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study, to Assess the Efficacy and Safety of XXXXX, and Placebo, in Female Patients
4. A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Dose-Ranging Study of XXXXX in Subjects with Functional Dyspepsia Gastroenterology Gastroesophageal Reflux Disease
5. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of XXXXX Alone, and in Combination with Omeprazole, Given Orally in Patients Suffering from Symptomatic (non-erosive) Gastroesophageal Reflux Disease(sGERD)
6. Post-Doctoral Fellowship Section of Digestive Diseases at Yale University & West Haven-VA Medical Center
7. Multi-Center, Randomized, Double-Blind, Placebo-Controlled Efficacy Study, Comparing Four Weeks of Treatment with XXXXX and XXXXX in Patients with Heartburn, and Sleep Disturbances, Associated with Gastroesophageal Reflux Disease (GERD) Gastroenterology-Hepatitis C Virus
8. A Comparison of the Safety and Efficacy of Two Doses of Peg-Interferon alfa-2b (PEG-Intron: 1.5 ug/kg vs. 3.0 ug/kg) in Combination with Ribavarin (Rebetol) Treatment of Chronic Hepatitis C Patients: Gastroenterology-Irritable Bowel Syndrome
